General News | Sep. 24, 2014

Foundation Welcomes NIH’s Accelerating Medicines Partnership in Lupus and RA Grantees

The Lupus Foundation of America congratulates and welcomes the first 11 new research groups that have been awarded grants as part of the Accelerating Medicines Partnership in Lupus and Rheumatoid Arthritis (AMP Lupus and RA) Network.

General News | Sep. 09, 2014

Leading Orgs Take to the Hill to Discuss Need to Accelerate New Medicines for Lupus & Other Diseases

Lupus Foundation of America and Rheumatology Research Foundation hold congressional briefing

Research News | Aug. 01, 2014

Clinical Trial of Adult Stem Cells Takes Another Step Forward

Study funded by the Foundation's National Lupus Research Program secures NIH planning grant to develop a multi-center trial of mesenchymal stem cells.

Research News | Jul. 31, 2014

Mixed Results for Phase II Clinical Study of Atacicept in Lupus

Flare rates among participants receiving a low dose of the b-cell blocker did not meet primary endpoint but were lower for individuals receiving a higher dose.

Research News | Jul. 21, 2014

Treat-to-Target in Lupus

An international group of lupus experts has developed a set of recommendations to implement the treat-to-target strategy for managing lupus.

General News | Jul. 01, 2014

A New Generation of Researchers Enlisted in the Fight to Solve the ‘Cruel Mystery’

Lupus Foundation of America announces its 2014 National Lupus Research Program Summer Fellowships and Career Development Awards

General News | Jun. 25, 2014

Dr. Bruce Richardson Receives Lupus Insight Prize Recognizing Outstanding Contribution in Research

Bruce Richardson, M.D., Ph.D., of the University of Michigan, was honored for his research findings that have made significant contributions to the field and have a high likelihood of generating further insights in understanding the disease.

General News | Mar. 18, 2014

Announcing a New Initiative to Improve Health and Quality of Life

LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential to greatly improve medical care and quality of life for people living with lupus.